Brain blood flow and sugar study for Alzheimer's and diabetes
Part of Brain & nervous system, Hormones & metabolism, Mental health clinical trials.
This study uses brain scans to see how blood flow and sugar transport work in people with both Alzheimer's disease and type 2 diabetes. It may help doctors understand how these conditions interact and find better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have suspected Alzheimer's disease
- You have type 2 diabetes (for one of the study groups)
- You are able and willing to follow the study procedures
- You do not have any other significant brain disease besides dementia
- You are not receiving active cancer treatment
- You have no history of alcohol or drug abuse
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares how the heart and brain work and how well people think between those with type 2 diabetes and healthy older adults. It aims to understand the effects of diabetes on these functions.
This study tests how consistent a special PET scan (called [15O]H2O-PET) is at measuring blood flow in the brain. It is for healthy older adults and involves cognitive testing and possibly light exercise.
This study tests a new way to measure how the brain uses sugar (glucose) to see if the hormone glucagon affects it. It may help researchers understand how certain hormones work in the body.
This study uses brain imaging to measure two things in the brain—amyloid protein and how the brain uses sugar. It may help researchers better understand early brain changes in people in the ALFA project.
This study uses PET/CT/MRI imaging to look for brain “imaging biomarkers” in people across the Alzheimer’s disease range. It may help researchers better understand how Alzheimer’s changes the brain over time and improve future treatments.
This study uses advanced brain scans to look at brain chemistry in people with type 2 diabetes, narrowed neck arteries, or early memory problems (MCI or early Alzheimer's). It aims to understand how these conditions affect the brain and may help improve future care.
Hear when a new Alzheimer Dementia (AD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.